Association between plasma levels and immunolocalization of cytokines in heart valve lesions: a possible target for treatment?

Bibliography

• American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons, Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-231
   PubMed Web of Science ®Google Scholar
• Branch KR, O'Brien KD, Otto CM. Aortic valve sclerosis as a marker of active atherosclerosis. Curr Cardiol Rep 2002;4:111-7
   Google Scholar
• Novaro GM, Griffin BP. Calcific aortic stenosis: another face of atherosclerosis? Cleve Clin J Med 2003;70:471-7
   PubMedGoogle Scholar
• Prasad Y, Bhalodkar NC. Aortic sclerosis – a marker of coronary atherosclerosis. Clin Cardiol 2004;27:671-3
   PubMedGoogle Scholar
• Davutoglu V, Celik A, Aksoy M. Contribution of selected inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class. J Heart Valve Dis 2005;14:251-6
   PubMed Web of Science ®Google Scholar
• Fae KC, Oshiro SE, Toubert A, et al. How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease. J Autoimmun 2005;24:101-9
   PubMedGoogle Scholar
• Chen D, Assad-Kottner C, Orrego C, Torre-Amione G. Cytokines and acute heart failure. Crit Care Med 2008;36:S9-16
   PubMed Web of Science ®Google Scholar
• Rawczynska-Englert I, Hryniewiecki T, Dzierzanowska D. Evaluation of serum cytokine concentrations in patients with infective endocarditis. J Heart Valve Dis 2000;9:705-9
   Google Scholar
• Chen MC, Chang HW, Wu CJ, et al. Balance between plasma levels of tumor necrosis factor-α and interleukin-10 in rheumatic mitral stenosis. Cardiology 2005;104:171-5
   PubMed Web of Science ®Google Scholar
• World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications Part I: Report of a WHO Consultation: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Heath Org., 2006. Available from: http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf [Last accessed 31 July 2008]
   Google Scholar
• Wallby L, Janerot-Sjoberg B, Steffensen T, Broqvist M. T Lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves. Heart 2002;88:348-51
   PubMed Web of Science ®Google Scholar
• Warren BA, Yong JL. Calcification of the aortic valve: its progression and grading. Pathology 1997;29:360-8
   PubMed Web of Science ®Google Scholar
• Popa C, Netea MG, van Riel PL, et al. The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 2007;48:751-62
   PubMed Web of Science ®Google Scholar
• Ghezzi P, Cerami A. Tumor necrosis factor as a pharmacological target. Mol Biotechnol 2005;31:239-44
   PubMed Web of Science ®Google Scholar
• Mei CL, Chen ZJ, Liao YH, et al. Interleukin-10 inhibits the down-regulation of ATP binding cassette transporter A1 by tumour necrosis factor-alpha in THP-1 macrophage-derived foam cells. Cell Biol Int 2007;31:1456-61
   Google Scholar
• Shkoda A, Ruiz PA, Daniel H, et al. Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation. Gastroenterology 2007;132:190-207
   PubMed Web of Science ®Google Scholar
• Yndestad A, Damas JK, Oie E, et al. Role of inflammation in the progression of heart failure. Curr Cardiol Rep 2007;9:236-41
   PubMedGoogle Scholar
• Balakumar P, Singh M. Anti-tumour necrosis factor-α therapy in heart failure: future directions. Basic Clin Pharmacol Toxicol 2006;99:391-7
   PubMed Web of Science ®Google Scholar
• Von Haehling S, Jankowska EA, Anker SD. Tumour necrosis factor-α and the failing heart – pathophysiology and therapeutic implications. Basic Res Cardiol 2004;99:18-28
   PubMed Web of Science ®Google Scholar
• Petersen JW, Felker GM. Inflammatory markers in heart failure. Congest Heart Fail 2006;12:324-8
   PubMedGoogle Scholar
• Batista ML Jr, Santos RV, Cunha LM, et al. Changes in the pro-inflammatory cytokine production and peritoneal macrophage function in rats with chronic heart failure. Cytokine 2006;23:284-90
   Google Scholar
• Kaden JJ, Kilic R, Sarikoc A, et al. Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanisms of valvular calcification. Int J Mol Med 2005;16:869-72
   PubMed Web of Science ®Google Scholar
• Kaden JJ, Dempfle CE, Grobholz R, et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol 2005;14:80-7
   PubMed Web of Science ®Google Scholar
• Bellamy MF, Pellikka PA, Klarich KW, et al. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002;40:1723-30
   PubMed Web of Science ®Google Scholar
• Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 2007;49:554-61
   PubMed Web of Science ®Google Scholar
• Yilmaz MB, Guray U, Guray Y, et al. Lipid profile of patients with aortic stenosis might be predictive of rate of progression. Am Heart J 2004;147:915-8
   PubMed Web of Science ®Google Scholar
• Helske S, Kupari M, Lindstedt KA, Kovanen PT. Aortic valve stenosis: an active atheroinflammatory process. Curr Opin Lipidol 2007;18:483-91
   PubMed Web of Science ®Google Scholar
• Rosenhek R, Baumgartner H. Aortic sclerosis, aortic stenosis and lipid-lowering therapy. Expert Rev Cardiovasc Ther 2008;6:385-90
   PubMedGoogle Scholar
• Paraskevas KI, Tzovaras AA, Briana DD, Mikhailidis DP. Emerging indications of statins: a pluripotent family of agents with several potential applications. Curr Pharm Des 2007;13:3622-36
   PubMed Web of Science ®Google Scholar
• Alnaeb ME, Alobaid N, Seifalian AM, et al. Statins and peripheral arterial disease: potential mechanisms and clinical benefits. Ann Vasc Surg 2006;20:696-705
   PubMed Web of Science ®Google Scholar
• Gazi IF, Liberopoulos EN, Athyros VG, et al. Statins and solid organ transplantation. Curr Pharm Des 2006;12:4771-83
   PubMed Web of Science ®Google Scholar
• Paraskevas KI. Applications of statins in cardiothoracic surgery: more than just lipid-lowering. Eur J Cardiothorac Surg 2008;33:377-90
   Google Scholar
• Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Endothelial function, arterial stiffness and lipid lowering drugs. Expert Opin Ther Targets 2007;11:1143-60
   PubMed Web of Science ®Google Scholar
• Novaro GM, Tiong IY, Pearce GL, et al. Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001;104:2205-9
   PubMed Web of Science ®Google Scholar
• Rajamannan NM, Subramaniam M, Caira F, et al. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation 2005;112(9 Suppl):I229-34
   PubMed Web of Science ®Google Scholar
• Rajamannan NM, Subramaniam M, Stock SR, et al. Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart 2005;91:806-10
   PubMed Web of Science ®Google Scholar
• Li JJ, Li YS, Fang CH, et al. Effects of simvastatin within two weeks on anti-inflammatory cytokine interleukin 10 in patients with unstable angina. Heart 2006;92:529-30
   PubMed Web of Science ®Google Scholar
• Li JJ, Fang CH. Effects of 4 weeks of atorvastatin administration on the antiinflammatory cytokine interleukin-10 in patients with unstable angina. Clin Chem 2005;51:1735-8
   Google Scholar
• Ascer E, Bertolami MC, Venturinelli ML, et al. Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients. Atherosclerosis 2004;177:161-6
   PubMed Web of Science ®Google Scholar
• Chua D, Kalb K. Statins and progression of calcified aortic stenosis. Ann Pharmacother 2006;40:2195-9
   PubMed Web of Science ®Google Scholar
• Mohler ER 3rd, Wang H, Medenilla E, Scott C. Effect of statin treatment on aortic valve and coronary artery calcification. J Heart Valve Dis 2007;16:378-86
   PubMedGoogle Scholar
• Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 2007;49:554-61
   PubMed Web of Science ®Google Scholar
• Antonini-Canterin F, Corrado G, Faggiano P, et al. A medical therapy for aortic valve sclerosis and aortic valve stenosis? Rationale of the ASSIST study (Asymptomatic aortic Sclerosis/Stenosis: Influence of STatins): a large, observational, prospective, multicenter study of the Italian Society of Cardiovascular Echography. J Cardiovasc Med (Hagerstown) 2006;7:464-9
   PubMed Web of Science ®Google Scholar
• Chan KL, Teo K, Tam J, Dumesnil JG; Astronomer Investigators. Rationale, design and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial. Am Heart J 2007;153:925-31
   PubMed Web of Science ®Google Scholar
• Rossebo AB, Pedersen TR, Allen C, et al. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Am J Cardiol 2007;99:970-3
   PubMed Web of Science ®Google Scholar
• Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention? Expert Opin Ther Targets 2008;12:809-20
   PubMed Web of Science ®Google Scholar